OTCM
NEVIF
Market cap419kUSD
Oct 05, Last price
0.01USD
1Q
-19.12%
IPO
-90.00%
Name
Pascal Biosciences Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
29.05%
Rev. gr., 5y
%
Revenues
2m
+9.40%
Net income
-275k
L-24.11%
CFO
62k
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nevis Brands Inc. engages in the development and sale of cannabis products in the United States. It offers hemp derived THC beverages under the Major brand name. The company was formerly known as Pascal Biosciences Inc. and changed its name to Nevis Brands Inc. in June 2023. Nevis Brands Inc. is headquartered in Seattle, Washington.
Key people
Carl Weissman
Acting President · since 2019
Judi Dalling
Chief Financial Officer, Secretary · since 2013
Thomas Deckwerth
Vice President - Therapeutic Development · since 2018
Kevin M. Egan
Vice President - Business Development · since 2018
Graeme I. Bell
Director · since 2017
Jens Biertumpel
Director · since 2015
Thomas R. Gadek
Director · since 2016
Terry Pearson
Director · since 2014
Headquarters & legal address
SUITE 500 - 666 BURRARD STREET
VANCOUVER, BC V6C 3P6
CA
VANCOUVER, BC V6C 3P6
CA
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑11 | 2024‑11 | 2023‑11 | 2022‑11 | 2021‑11 | 2020‑11 | 2019‑11 | 2018‑11 | 2017‑11 | 2016‑11 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT |